Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 December 2020 | Story André Damons | Photo Supplied
Dr Michael Pienaar is a lecturer in the University of the Free State’s (UFS) department of Paediatrics and Child Health.

A lecturer from the University of the Free State’s (UFS) department of Paediatrics and Child Health is investigating the use of artificial neural networks to develop models for the prediction of patient outcomes in children with severe illness.

Dr Michael Pienaar, senior lecturer and specialist, is conducting this research as part of his doctoral research and the study deals primarily with the development of models that are designed and calibrated for use in South Africa. These artificial neural networks are computer programs designed to mimic some of the learning characteristics of biological neurons.

The potential applications of models

According to Dr Pienaar these models have traditionally been developed in high-income nations using conventional statistical methods.

“The potential applications of such models in the clinical setting include triage, medical research, guidance of resource allocation and quality control. Having initially begun this research investigating the prediction of mortality outcomes in the paediatric intensive care unit (PICU) I have broadened my scope to patients outside of PICU, seeking to identify children early during their illnesses who are at risk of serious illness requiring PICU,” says Dr Pienaar.

The research up until now has been directed towards the identification of characteristics that are both unique to children with serious illness in South Africa, but also accessible to clinicians in settings where expertise and technical resources are limited.

Research still in the early changes

The research is still in its early stages but next year a series of expert review panels will be held to investigate the selection of variables for the model, after which the collection of clinical data will begin. Once the data has been collected and prepared, a number of candidate models will be developed and evaluated. This should be concluded by the end of 2022.

Says Dr Pienaar: “The need to engage with the rapid proliferation of technology, particularly in the realms of machine learning, mobile technology, automation and the Internet of Things is as great in medical research now as it is in any academic discipline.

“It is critical that research, particularly in South Africa, engage with this in order to take advantage of the opportunities offered and avoid the dangers that go paired with them. Together with the technology as such, it has been essential to pursue this project as an interdisciplinary undertaking involving clinicians, biostatisticians and computer engineers.”

Hope for the research  

Dr Pienaar says he was very fortunate and grateful to be the recipient of a generous interdisciplinary grant from the UFS which has allowed him to procure software and equipment that is critical to this project.

“The hope for this research is that the best performing of these models can be integrated with a mobile application that assists practitioners in a wide range of settings in the identification, treatment and early referral of children at high risk of severe illness. I would like to expand this research project to include other countries in Africa and South America and to use it as a bridge to collaboration with other clinical researchers in the Global South,” says Dr Pienaar.

As an early career researcher, Dr Pienaar hopes that this research can serve as a platform to build a body of research that uses the rapid technological advances of these times together with a wide range of collaborations with other disciplines in the pursuit of better child health.

He concludes by saying that he has had excellent support thus far from his supervisors, Prof Stephen Brown (Faculty of Health Sciences, UFS), Dr Nicolaas Luwes (Faculty of Computer Science and Engineering, Central University of Technology) and Dr Elizabeth George (Medical Research Council Clinical Trials Unit, University College London). I have also been supported by the Robert Frater Institute in the Faculty of Health Sciences.

News Archive

Using sugar to make the world a sweeter place
2017-10-13

Description: Deepback sugar Tags: Sugarcane, Dr Deepack Santchurn, Mauritius Sugar Industry Research Institute (MSIRI), Department of Plant Sciences 

Dr Deepack Santchurn, former PhD student in the
Department of Plant Sciences at the UFS,
and plant breeder in the  Mauritius Sugar Industry
Research Institute, with Prof Maryke Labuschagne, left,
Dr Santchurn’s study leader.
Photo: Charl Devenish



Besides it mainly being used for sugar production, sugarcane has emerged as an important alternative for providing clean renewable energy. Dr Deepack Santchurn, who works in the sugarcane breeding department of the Mauritius Sugar Industry Research Institute (MSIRI), believes if he could contribute towards a more environment-friendly and renewable energy through the use of sugarcane biomass, he would consider himself having made a great leap towards a better world. 

Sugarcane is mostly known and exploited for the sugar in its cane stem. According to Dr Santchurn it is not the only thing the crop does well. “Together with certain grasses, it is the finest living collector of sunlight energy and a producer of biomass in unit time. Sugarcane is now recognised worldwide as a potential renewable and environment-friendly bioenergy crop.” 

Significantly more bioenergy can be produced from sugarcane if the production system is not focused on the production and recovery of sucrose alone but on the maximum use to the total above-ground biomass. Diversification within the sugarcane industry is of paramount importance. 

He has been able to identify a few high biomass varieties that can be exploited industrially. One of the varieties is a commercial type with relatively high sugar and low fibre in the cane stem. Dr Santchurn explains: “Its sucrose content is about 0.5% less than the most cultivated commercial variety in Mauritius. Nevertheless, its sugar yield and above-ground biomass yield surpass those of the commercial varieties by more than 24%. The genetic gains compared to commercial varieties were around +50% for total biomass yield and +100% for fibre yield. Its cultivation is strictly related to bio-energy production and the extracted juice can be used as a feed-stock for ethanol and other high-value products.”

Dr Santchurn received his PhD at the UFS’s Department of Plant Sciences during the Winter Graduation Ceremonies in June this year. His study leader was Prof Maryke Labuschagne from the Department of Plant Sciences. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept